Related Experiment Video
Updated: Jul 20, 2026
03:55
Computer-Aided Three-Dimensional Visualization in the Treatment of Locally Advanced Thyroid Cancer
Published on: June 9, 2023
Thyroid-hormone therapy and thyroid cancer: a reassessment
Bernadette Biondi1, Sebastiano Filetti, Martin Schlumberger
1Department of Clinical and Molecular Endocrinology and Oncology, University of Naples Federico II, Naples, Italy. bebiondi@unina.it
Nature Clinical Practice. Endocrinology & Metabolism
|August 25, 2006
Summary
Thyroid-stimulating hormone (TSH) suppression benefits high-risk thyroid cancer patients. However, TSH suppression is not beneficial for low-risk patients and requires careful monitoring for side effects.
Area of Science:
- Endocrinology
- Oncology
Background:
- Thyroid-cell proliferation is regulated by thyroid-stimulating hormone (TSH).
- TSH suppression using L-enantiomer of tetraiodothyronine (L-T(4)) is a treatment strategy for differentiated thyroid cancer.
- Complex regulatory mechanisms, including TSH-independent pathways, influence thyroid-cell regulation.
Purpose of the Study:
- To evaluate the efficacy of TSH suppression in differentiated thyroid cancer treatment.
- To differentiate the treatment approach for high-risk versus low-risk thyroid cancer patients.
Main Methods:
- Review of experimental studies and clinical data on TSH suppression therapy.
- Analysis of treatment outcomes based on patient risk stratification (high-risk vs. low-risk).
Main Results:
- Hormone-suppressive treatment with L-T(4) reduces progression, recurrence, and mortality in high-risk thyroid cancer patients.
- TSH suppression showed no significant improvement in low-risk thyroid cancer patients.
- TSH suppression can lead to subclinical thyrotoxicosis, necessitating careful monitoring.
Conclusions:
- TSH suppression is beneficial for selected high-risk differentiated thyroid cancer patients.
- For low-risk patients, L-T(4) treatment aims for normal TSH levels (0.5-2.5 mU/l).
- Long-term TSH suppression in high-risk patients requires monitoring for potential bone and cardiac side effects.
Related Concept Videos
01:27Hyperthyroidism II: Pathophysiology
Hyperthyroidism is a hypermetabolic state caused by elevated levels of thyroid hormones, triiodothyronine (T3) and thyroxine (T4). It results from dysregulation at the thyroid, pituitary, or immune system level and affects multiple organ systems.PathophysiologyThe most common cause of hyperthyroidism is Graves’ disease, an autoimmune disorder in which antibodies, specifically thyroid-stimulating antibodies (TSAb), a subtype of TSH receptor antibodies (TRAb), bind to and activate TSH receptors...
01:23Hypothyroidism II: Pathophysiology
Hypothyroidism is a disorder characterized by insufficient production of thyroid hormones, which regulate metabolism, energy balance, and multiple organ systems.TypesHypothyroidism is classified based on the level of dysfunction. Primary hypothyroidism results from intrinsic thyroid gland dysfunction, causing reduced hormone production despite normal or increased stimulation. Secondary hypothyroidism arises from inadequate thyroid-stimulating hormone (TSH) secretion by the pituitary. Tertiary...
01:25Hyperthyroidism I: Introduction
Hyperthyroidism is a type of thyrotoxicosis characterized by the thyroid gland's overproduction of the thyroid hormones triiodothyronine (T3) and thyroxine (T4). This hormone excess increases the basal metabolic rate and enhances sensitivity to catecholamines.DiagnosisDiagnosis is based on clinical features and biochemical testing. It typically shows suppressed thyroid-stimulating hormone (TSH) levels below 0.4 mIU/L, with elevated free T3 and/or T4. Additional tests, including thyroid...
01:20Synthesis and Regulation of Thyroid Hormones
Low blood levels of the thyroid hormones — triiodothyronine (T3) and thyroxine (T4) — signal the hypothalamus to release the thyrotropin-releasing hormone (TRH). TRH then reaches the pituitary gland and stimulates the release of thyroid-stimulating hormone(TSH) into the bloodstream.
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The iodine is then...
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The iodine is then...
01:27Tumor Immunotherapy
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
02:49Cancer Therapies
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...